These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36868476)

  • 1. Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique.
    Gbaguidi GN; Aubert L; Schaeffer J; Fagour L; Dubremetz A; Enouf V; Glaudon-Louveau de la Guigneraye MH; Nestour F; Rosine J; Dos Santos G
    Infect Dis Now; 2023 Jun; 53(4):104690. PubMed ID: 36868476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
    Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
    BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.
    Ma KC; Shirk P; Lambrou AS; Hassell N; Zheng XY; Payne AB; Ali AR; Batra D; Caravas J; Chau R; Cook PW; Howard D; Kovacs NA; Lacek KA; Lee JS; MacCannell DR; Malapati L; Mathew S; Mittal N; Nagilla RR; Parikh R; Paul P; Rambo-Martin BL; Shepard SS; Sheth M; Wentworth DE; Winn A; Hall AJ; Silk BJ; Thornburg N; Kondor R; Scobie HM; Paden CR
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(24):651-656. PubMed ID: 37319011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador.
    Carrazco-Montalvo A; Herrera-Yela A; Alarcón-Vallejo D; Gutiérrez-Pallo D; Armendáriz-Castillo I; Andrade-Molina D; Muñoz-Mawyin K; Fernández-Cadena JC; Morey-León G; Usfq-Covid-Consortium ; Crn Influenza Y Ovr-Inspi ; Patiño L
    Viruses; 2022 May; 14(6):. PubMed ID: 35746651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
    Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
    Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan.
    Shao PL; Tu HC; Gong YN; Shu HY; Kirby R; Hsu LY; Yeo HY; Kuo HY; Huang YC; Lin YF; Weng HY; Wu YL; Chen CC; Chen TW; Lee KM; Huang CG; Shih SR; Chen WJ; Wu CC; Yu CJ; Tsai SF
    Emerg Infect Dis; 2023 Apr; 29(4):792-796. PubMed ID: 36918378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 wastewater monitoring using a novel PCR-based method rapidly captured the Delta-to-Omicron ΒΑ.1 transition patterns in the absence of conventional surveillance evidence.
    Chassalevris T; Chaintoutis SC; Koureas M; Petala M; Moutou E; Beta C; Kyritsi M; Hadjichristodoulou C; Kostoglou M; Karapantsios T; Papadopoulos A; Papaioannou N; Dovas CI
    Sci Total Environ; 2022 Oct; 844():156932. PubMed ID: 35753493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.
    Vauhkonen H; Nguyen PT; Kant R; Plyusnin I; Erdin M; Kurkela S; Liimatainen H; Ikonen N; Blomqvist S; Liitsola K; Lindh E; Helve O; Jarva H; Loginov R; Palva A; Hannunen T; Hannula S; Parry M; Kauppi P; Vaheri A; Sironen T; Lappalainen M; Savolainen-Kopra C; Smura T; Vapalahti O
    Emerg Infect Dis; 2022 Jun; 28(6):1229-1232. PubMed ID: 35378057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages.
    Kumar N; Kaushik R; Singh A; Uversky VN; Zhang KYJ; Sahu U; Bhatia S; Sanyal A
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulation of SARS-CoV-2 Omicron sub-lineages revealed by multiplex genotyping RT-qPCR assays for sewage surveillance.
    Ding J; Xu X; Deng Y; Zheng X; Zhang T
    Sci Total Environ; 2023 Dec; 904():166300. PubMed ID: 37591390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of the Omicron Variant and Its Sub-Lineages among Residents and Travelers in Its First Year of Emergence in Venezuela.
    Moros ZC; Zambrano JL; Sulbaran Y; Loureiro CL; Marulanda E; Bracho F; D'Angelo P; Rodríguez L; Liprandi F; Rangel HR; Jaspe RC; Pujol FH
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5.
    Torres C; Nabaes Jodar M; Acuña D; Montaño RMZ; Culasso ACA; Amadio AF; Aulicino P; Ceballos S; Cacciabue M; Debat H; Dus Santos MJ; Eberhardt MF; Espul C; Fay F; Fernández MA; Fernández F; Muñoz JMF; Ferrini F; Gallego F; Giri AA; Cerri A; Bolatti E; Gismondi MI; Goya S; Gramundi I; Irazoqui JM; König GA; Leiva V; Lucero H; Marquez N; Nardi C; Ortiz B; Pianciola L; Pintos CB; Puebla AF; Rastellini CV; Rojas AE; Sfalcin J; Suárez A; Tittarelli E; Toro R; Villanova GV; Ziehm MC; Zimmermann MC; Zunino S; Proyecto Pais Working Group ; Valinotto L; Viegas M
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France.
    Bal A; Simon B; Destras G; Chalvignac R; Semanas Q; Oblette A; Quéromès G; Fanget R; Regue H; Morfin F; Valette M; Lina B; Josset L
    Nat Commun; 2022 Oct; 13(1):6316. PubMed ID: 36274062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring algorithm of hospitalized patients in a medical center with SARS-CoV-2 (Omicron variant) infection: clinical epidemiological surveillance and immunological assessment.
    Chen CS; Jian MJ; Chang CK; Chung HY; Li SY; Lin JC; Yeh KM; Yang YS; Chen CW; Hsieh SS; Tang SH; Perng CL; Chang FY; Shang HS
    PeerJ; 2023; 11():e14666. PubMed ID: 36710871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
    Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.